Abstract:Deletions of the long arm of chromosome 20 (20q) are rare, with only 16 reported patients displaying a proximal interstitial 20q deletion. A 1.62 Mb minimal critical region at 20q11.2, encompassing three genes GDF5, EPB41L1, and SAMHD1, is proposed to be responsible for this syndrome. The leading clinical features include growth retardation, intractable feeding difficulties with gastroesophageal reflux, hypotonia and psychomotor developmental delay. Common facial dysmorphisms including triangular face, hypertelorism, and hypoplastic alae nasi were additionally reported. Here, we present the clinical and molecular findings of five new patients with proximal interstitial 20q deletions. We analyzed the phenotype and molecular data of all previously reported patients with 20q11.2q12 microdeletions, along with our five new cases. Copy number variation analysis of patients in our cohort has enabled us to identify the second critical region in the 20q11.2q12 region and redefine the first region that is initially identified. The first critical region spans 359 kb at 20q11.2, containing six MIM genes, including two disease‐causing genes, GDF5 and CEP250. The second critical region spans 706 kb at 20q12, encompassing four MIM genes, including two disease‐causing genes, MAFB and TOP1. We propose GDF5 to be the primary candidate gene generating the phenotype of patients with 20q11.2 deletions. Moreover, we hypothesize TOP1 as a potential candidate gene for the second critical region at 20q12. Of note, we cannot exclude the possibility of a synergistic role of other genes involved in the deletion, including a contiguous gene deletion syndrome or position effect affecting both critical regions. Further studies focusing on patients with proximal 20q deletions are required to support our hypothesis.

5q14.3 Microdeletion Syndrome With Simultaneous Involvement of MEF2C and RASA1. Clinical Case and Review of the Literature

5q14.3 neurocutaneous syndrome: A novel continguous gene syndrome caused by simultaneous deletion of RASA1 and MEF2C

Clinical Features in Patients with Xq23 Microdeletion: A Case Report and Literature Review

The MEF2C-Related and 5q14.3q15 Microdeletion Syndrome

Microdeletion 5q14.3 and anomalies of brain development

Cleft Lip Palate in a Patient with 5q14.3 Deletion Syndrome: A Possible Unreported Feature?

De novo microdeletion of 5q14.3 excluding MEF2C in a patient with infantile spasms, microcephaly, and agenesis of the corpus callosum

2q31 microdeletion syndrome with the velocardiofacial phenotype and review of the literature: a case report

[20q11.2 microdeletion syndrome: a phenotypic spectrum expansion. Case report]

MEF2C-Related 5q14.3 Microdeletion Syndrome Detected by Array CGH: A Case Report

A Comprehensive and Clinical Review of Distal Deletion Syndrome of Chromosome 5q14.3

MEF2C deletions and mutations versus duplications: a clinical comparison

Clinical and Genetic Heterogeneity of the 15q13.3 Microdeletion Syndrome

A Case with 4 De Novo Copy Number Variations with Clinical Features That Overlap 1q43q44 Microdeletion and 3q29 Microduplication Syndromes.

Myoclonus dystonia plus syndrome due to a novel 7q21 microdeletion

Clinical and molecular cytogenetic studies of five new patients with 20q11q12 deletion and review of the literature: Proposition of two critical regions

Microdeletion of 12q24.31: Report of a girl with intellectual disability, stereotypies, seizures and facial dysmorphisms

Special clinical entity with 15q26 deletion: a novel case report

Clinical and Genetic Analysis of Three Pediatric Patients with 15q24 Microdeletion Syndrome

Early Diagnosis of the Chromosomal Deletion 5q14.2-q21.3 in a Preterm Newborn: Case Report

[Clinical and Genetic Analysis of a Fetus with 17q12 Microdeletion Syndrome].